Frank M. Svoboda, Co-Chairman and CEO of Globe Life Inc. (NASDAQ: GL), executed a series of stock sales totaling $3,315,645 in mid-June 2026. The transactions involved the liquidation of 20,000 shares of common stock across June 11 and June 12. These sales were directly preceded by the acquisition of an equivalent number of shares through the exercise of employee stock options.
On June 11, Svoboda sold 2,630 shares at prices ranging from $163.935 to $164.885 per share. He also sold an additional 7,370 shares at prices between $164.91 and $165.355 per share. These sales followed the acquisition of 10,000 shares via option exercises priced at $100.74 per share.
The following day, June 12, the executive sold 4,366 shares at prices ranging from $165.635 to $166.595 per share. He also sold 5,634 shares at prices between $166.605 and $167.425 per share. Similar to the previous day, these sales were preceded by the acquisition of 10,000 shares through option exercises at $100.74 per share. The total value of shares acquired through these exercises amounted to $2,014,800.
Following these transactions, Svoboda directly holds 54,020.4648 shares of Globe Life common stock. He also maintains indirect holdings through various trusts and plans: 103,473 shares via a Family Trust, 5,000 shares through an Irrevocable Trust, 26,425 shares through a Spouse’s Irrevocable Trust, and 1,955.294 shares in a 401(k) Plan.
Globe Life reported its first-quarter 2026 earnings, showing a slight miss in earnings per share (EPS) expectations. The company posted an EPS of $3.43, compared to the forecasted $3.48, resulting in a 1.44% negative surprise. However, revenue aligned with expectations, coming in at $1.56 billion.
Several analyst firms have adjusted their price targets for Globe Life stock. Raymond James raised its price target to $208, maintaining a Strong Buy rating, citing the company’s strong cash flow generation. BMO Capital increased its price target to $150, with a Market Perform rating, after Globe Life raised its cash flow guidance midpoint by 4% to $675 million. Truist Securities also adjusted its price target to $185, maintaining a Buy rating and increasing its 2026 EPS estimate to $15.60.